Genetic control of glycoprotein 70 autoantigen production and its influence on immune complex levels and nephritis in murine lupus.
The F1 hybrids of New Zealand Black (NZB) and New Zealand White (NZW) mice spontaneously develop an autoimmune disease that serves as a model for human systemic lupus erythematosus. Autoimmunity in (NZB x NZW)F1 mice includes the production of autoantibodies to the endogenous retroviral envelope glycoprotein, gp70, and gp70-anti-gp70 immune complexes (gp70 IC) have been implicated in the development of lupus nephritis in these animals. We used backcross and intercross combinations of C57BL/6 (B6; low gp70 levels) and NZB mice (high gp70 levels) to examine the contribution of serum gp70 Ag levels to the development of gp70 IC and nephritis. Analysis of (B6.H2z x NZB)F1 x NZB backcross mice and (NZB x B6)F2 mice showed a much stronger association of gp70 IC with kidney disease compared with IgG anti-chromatin autoantibodies in both populations of mice. Serum levels of gp70 correlated with production of gp70 IC in mice producing autoantibodies, although the overall effect on nephritis appeared to be small. Genetic mapping revealed three NZB-derived regions on chromosomes 2, 4, and 13 that were strongly linked with increased gp70 levels, and together, accounted for over 80% of the variance for this trait. However, additional linkage analyses of these crosses showed that loci controlling autoantibody production rather than gp70 levels were most important in the development of nephritogenic immune complexes. Together, these studies characterize a set of lupus-susceptibility loci distinct from those that control autoantibody production and provide new insight into the components involved in the strong association of gp70 IC with murine lupus nephritis.
Tucker
R M
RM
Department of Medicine and Immunology, University of Colorado Health Sciences Center, Denver, CO 80262, USA.
Vyse
T J
TJ
Rozzo
S
S
Roark
C L
CL
Izui
S
S
Kotzin
B L
BL
D000818:Animals; D000936:Antigen-Antibody Complex / Q000097:blood*; D001323:Autoantibodies / Q000096:biosynthesis / Q000235:genetics; D001324:Autoantigens / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics* / Q000276:immunology; D003433:Crosses, Genetic; D005260:Female; D008040:Genetic Linkage / Q000276:immunology; D005819:Genetic Markers / Q000276:immunology; D020022:Genetic Predisposition to Disease; D006023:Glycoproteins / Q000096:biosynthesis* / Q000097:blood / Q000235:genetics* / Q000276:immunology; D008181:Lupus Nephritis / Q000097:blood / Q000235:genetics* / Q000276:immunology*; D008297:Male; D051379:Mice; D020297:Mice, Congenic; D008810:Mice, Inbred C57BL; D008814:Mice, Inbred NZB; D011110:Polymorphism, Genetic / Q000276:immunology
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D001324:Autoantigens; D005819:Genetic Markers; D006023:Glycoproteins; C033589:glycoprotein gp70, murine serum